BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 23759933)

  • 1. Precursor lesions of mucinous carcinoma of the breast: analysis of 130 cases.
    Kryvenko ON; Chitale DA; Yoon J; Arias-Stella J; Meier FA; Lee MW
    Am J Surg Pathol; 2013 Jul; 37(7):1076-84. PubMed ID: 23759933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of MUC1, MUC2, MUC5AC and MUC5B in mucinous lesions of the breast.
    Kim D; Jung WH; Koo JS
    Pathobiology; 2012; 79(3):144-53. PubMed ID: 22269464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neovascularization in mucinous ductal carcinoma in situ suggests an alternative pathway for invasion.
    Gadre SA; Perkins GH; Sahin AA; Sneige N; Deavers MT; Middleton LP
    Histopathology; 2008 Nov; 53(5):545-53. PubMed ID: 18983463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucinous lesions of the breast. A pathological continuum.
    Weaver MG; Abdul-Karim FW; al-Kaisi N
    Pathol Res Pract; 1993 Sep; 189(8):873-6. PubMed ID: 8302709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The significance of extracellular mucin in breast fine needle aspiration specimens.
    Shield PW; Ribu DL; Cominos D
    Cytopathology; 2016 Jun; 27(3):185-92. PubMed ID: 26104545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraductal papillary mucinous neoplasm (IPMN) of the pancreas: its histopathologic difference between 2 major types.
    Ban S; Naitoh Y; Mino-Kenudson M; Sakurai T; Kuroda M; Koyama I; Lauwers GY; Shimizu M
    Am J Surg Pathol; 2006 Dec; 30(12):1561-9. PubMed ID: 17122512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast density, scintimammographic (99m)Tc(V)DMSA uptake, and calcitonin gene related peptide (CGRP) expression in mixed invasive ductal associated with extensive in situ ductal carcinoma (IDC + DCIS) and pure invasive ductal carcinoma (IDC): correlation with estrogen receptor (ER) status, proliferation index Ki-67, and histological grade.
    Papantoniou V; Sotiropoulou E; Valsamaki P; Tsaroucha A; Sotiropoulou M; Ptohis N; Stipsanelli A; Dimitrakakis K; Marinopoulos S; Tsiouris S; Antsaklis A
    Breast Cancer; 2011 Oct; 18(4):286-91. PubMed ID: 20143189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraductal papillary mucinous neoplasm of the pancreas: cytologic features predict histologic grade.
    Michaels PJ; Brachtel EF; Bounds BC; Brugge WR; Pitman MB
    Cancer; 2006 Jun; 108(3):163-73. PubMed ID: 16550572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucinous endometrial epithelial proliferations: a morphologic spectrum of changes with diverse clinical significance.
    Nucci MR; Prasad CJ; Crum CP; Mutter GL
    Mod Pathol; 1999 Dec; 12(12):1137-42. PubMed ID: 10619266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between nuclear grade of ductal carcinoma in situ and cell origin markers.
    Tang P; Wang X; Schiffhauer L; Wang J; Bourne P; Yang Q; Quinn A; Hajdu SI
    Ann Clin Lab Sci; 2006; 36(1):16-22. PubMed ID: 16501232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucinous cystadenocarcinoma of the breast coexisting with infiltrating ductal carcinoma.
    Chen WY; Chen CS; Chen HC; Hung YJ; Chu JS
    Pathol Int; 2004 Oct; 54(10):781-6. PubMed ID: 15482568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
    Ottesen GL
    APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solid papillary ductal carcinoma in situ versus usual ductal hyperplasia in the breast: a potentially difficult distinction resolved by cytokeratin 5/6.
    Rabban JT; Koerner FC; Lerwill MF
    Hum Pathol; 2006 Jul; 37(7):787-93. PubMed ID: 16784976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytology of mucinous carcinoma of breast: a report of 28 cases with histological correlation.
    Jayaram G; Swain M; Chew MT; Yip CH; Moosa F
    Malays J Pathol; 2000 Dec; 22(2):65-71. PubMed ID: 16329537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fine-needle aspiration cytology findings of an uncommon micropapillary variant of pure mucinous carcinoma of the breast: review of patients over an 8-year period.
    Ng WK
    Cancer; 2002 Oct; 96(5):280-8. PubMed ID: 12378595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucin gene expression in intraductal papillary-mucinous pancreatic tumours and related lesions.
    Terris B; Dubois S; Buisine MP; Sauvanet A; Ruszniewski P; Aubert JP; Porchet N; Couvelard A; Degott C; Fléjou JF
    J Pathol; 2002 Aug; 197(5):632-7. PubMed ID: 12210083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocrine ductal carcinoma in situ (E-DCIS) of the breast: a form of low-grade DCIS with distinctive clinicopathologic and biologic characteristics.
    Tsang WY; Chan JK
    Am J Surg Pathol; 1996 Aug; 20(8):921-43. PubMed ID: 8712293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cystic papillary pattern in pancreatic ductal adenocarcinoma: a heretofore undescribed morphologic pattern that mimics intraductal papillary mucinous carcinoma.
    Kelly PJ; Shinagare S; Sainani N; Hong X; Ferrone C; Yilmaz O; Fernández-del Castillo C; Lauwers GY; Deshpande V
    Am J Surg Pathol; 2012 May; 36(5):696-701. PubMed ID: 22367300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of cytokeratin markers, ER-alpha, PR, HER-2/neu, and EGFR in pure ductal carcinoma in situ (DCIS) and DCIS with co-existing invasive ductal carcinoma (IDC) of the breast.
    Steinman S; Wang J; Bourne P; Yang Q; Tang P
    Ann Clin Lab Sci; 2007; 37(2):127-34. PubMed ID: 17522367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucinous micropapillary carcinoma of the breast: an aggressive counterpart to conventional pure mucinous tumors.
    Barbashina V; Corben AD; Akram M; Vallejo C; Tan LK
    Hum Pathol; 2013 Aug; 44(8):1577-85. PubMed ID: 23517923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.